Trump Says He ‘Probably Should’ Take Obesity Drugs, but Has Not
The New York Times••world
Key Points:
- President Trump confirmed in a New York Times interview that he has never taken GLP-1 obesity drugs like Wegovy and Ozempic, though he acknowledged he "probably should."
- In 2020, Trump weighed 244 pounds, classified as obese for his height, but by April 2025, his weight had decreased to 224 pounds, placing him in the overweight category.
- The Trump administration has worked to reduce the cost of popular obesity drugs, announcing a deal in November that could lower prices to as little as $149 per month.
- During an Oval Office event promoting the drug pricing deal, Trump inquired about aides' use of these drugs, noting that some had not taken them, while suggesting White House communications director Steven
